Speakers:
- Ian Morrissey, Consultant, Antimicrobial Focus Ltd. (UK)
- Rebecca Li, CEO, Vivli (USA)
- Patricia Bradford, Consultant, Antimicrobial Development Specialists LLC (USA)
Moderator: Fernanda Lessa, Chief of International Infection Control, Centers for Disease Control and Prevention (USA)
We apologise for the technical difficulties that you may have experienced during the broadcasting of this REVIVE webinar on 23 July. These issues resulted in the session not being fully recorded.
Our regular attendees will know that this is the first time we have issues like this in the 6 years that we have been holding these webinars. Our webinar speakers have kindly agreed to record their presentations again which you can watch here. The recording of the Q&A session is unavailable.
Schedule:
0:00 Webinar opening words
03:45 Presentation 1: Antimicrobial resistance surveillance and new drug development (Ian Morrissey)
24:39 Presentation 2: The Vivli AMR Register – a mechanism for sharing and re-use for industry surveillance (Rebecca Li)
35:02 Presentation 3: The Vivli AMR Surveillance Data Challenge (Patricia Bradford)
GARDP: [ Ссылка ]
REVIVE: [ Ссылка ]
#webinar #GARDP #REVIVE #amr #antibiotics #researchanddevelopment #discovery
